Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions (SOTHIS)

AbbVie

Status: Completed

Conditions: Ulcerative Colitis (UC)

Study type: Observational

Funder types: Industry

Identifiers

NCT02738125

P15-681

Details and patient eligibility

About

This study assesses the long?term effectiveness of adalimumab in subjects starting a treatment for ulcerative colitis in real life conditions, namely to describe the time to loss of clinical benefit in a time to event approach.

Enrollment: 265 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Suffering from ulcerative colitis
• Naïve from Adalimumab
• Starting a treatment with adalimumab
• Capable of and willing to grant authorization for use/disclosure of data collected
• Able to read, understand, and complete patients questionnaires

Exclusion criteria

• None

Trial design

265 participants in 1 patient group

Subjects starting/ receiving adalimumab

Description:

Subjects starting/ receiving Adalimumab for UC